Nifedipine and cyclosporin affect fibroblast calcium and gingiva

Journal of Dental Research

Volumn 86, Issue 4, 2007, Pages 357-362

  Bullon, P ^a   Gallardo, I ^a   Goteri, G ^b   Rubini, C ^b   Battino, M ^b   Ribas, J ^a   Newman, H N ^c  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cyclosporin A; Fura; Gingival overgrowth; Intracellular calcium; Nifedipine

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; NIFEDIPINE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; FIBROBLAST; GINGIVA; GINGIVA OVERGROWTH; MALE; METABOLISM; MICROCIRCULATION; RANDOMIZATION; RAT; VASCULARIZATION;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; COLLAGEN; CYCLOSPORINE; FIBROBLASTS; GINGIVA; GINGIVAL OVERGROWTH; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROCIRCULATION; NIFEDIPINE; RANDOM ALLOCATION; RATS;

EID: 34247229835     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600411     Document Type: Article

References (28)

1. Arora PD, Bibby KJ, McCulloch CA (1994). Slow oscillations of free intracellular calcium ion concentration in human fibroblasts responding to mechanical stretch. J Cell Physiol 161:187-200.
2. Arzate H, Alvarez MA, Narayanan AS (2005). Cyclosporin A promotes mineralization by human cementoblastoma-derived cells in culture. J Periodontal Res 40:218-224.
3. Ayanoglou CM, Lesty C (1999). Cyclosporin A-induced gingival overgrowth in the rat: a histological, ultrastructural and histomorphometric evaluation. J Periodontal Res 34:7-15.
4. Barclay S, Thomason JM, Idle JR, Seymour RA (1992). The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 19:311-314.
5. Bonakdar MP, Barber PM, Newman HN (1997). The vasculature in chronic adult periodontitis: a qualitative and quantitative study. J Periodontol 68:50-58.
6. Bonnaure-Mallet M, Tricot-Doleux S, Godeau GJ (1995). Changes in extracellular matrix macromolecules in human gingiva after treatment with drugs inducing gingival overgrowth. Arch Oral Biol 40:393-400.
7. 2+ ions. Nephrol Dial Transplant 18:2262-2268.
8. Dusseau J, Hutchins PM (1993). Calcium entry blockers stimulate vasoproliferation on the chick chorioallantoic membrane. Int J Microcirc Clin Exp 13:219-231.
9. Frolov VA (2003). Experimental study of myocardial collagen during nifedipine therapy of arterial hypertension. Bull Exp Biol Med 135:16-18.
10. Gagliano N, Moscheni C, Dellavia C, Stabellini G, Ferrario VF, Gioia M (2005). Immunosuppression and gingival overgrowth: gene and protein expression profiles of collagen turnover in FK506-treated human gingival fibroblasts. J Clin Periodontol 32:167-173.
11. Gelfand EW, Cheung RK, Mills GB (1987). The cyclosporines inhibit lymphocyte activation at more than one site. J Immunol 138:1115-1120.
12. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He CS (1989). Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloprotease designated TIMP-2. Proc Natl Acad Sci USA 86:8207-8211.
13. Grynkiewicz G, Poenie M, Tsien RY (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
14. Hallmon WW, Rossmann JA (1999). The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts. Periodontol 2000 21:176-196.
15. Henderson JS, Flynn JC, Tucci MA, Tsao AK, Zebrowski EJ, Odlum O, et al. (1997). Site-specific variations in metabolism by human fibroblasts exposed to nifedipine in vitro. J Oral Pathol Med 26:6-10.
16. Hyland PL, Traynor PS, Myrillas TT, Marley JJ, Linden GJ, Winter P, et al. (2003). The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. J Periodontol 74:437-445.
17. Kataoka M, Shimizu Y, Kunikiyo K, Asahara Y, Azuma H, Sawa T, et al. (2001). Nifedipine induces gingival overgrowth in rats through a reduction in collagen phagocytosis by gingival fibroblasts. J Periodontol 72:1078-1083.
18. Lim BJ, Kim PK, Hong SW, Jeong HJ (2004). Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity. Pediatr Nephrol 19:288-294.
19. Lo Russo A, Passaquin AC, Cox C, Ruegg UT (1997). Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Recept Signal Transduct Res 17:149-161.
20. Maita E, Sato M, Yamaki K. (2004). Effect of tranilast on matrix metalloproteinase-1 secretion from human gingival fibroblasts in vitro. J Periodontol 75:1054-1060.
21. McCulloch CA (2004). Drug-induced fibrosis: interference with the intracellular collagen degradation pathway. Curr Opin Drug Discov Devel 7:720-724.
22. McGaw WT, Porter H (1988). Cyclosporine-induced gingival overgrowth: an ultrastructural stereological study. Oral Surg Oral Med Oral Pathol 65:186-190.
23. Munshi HG, Wu YI, Ariztia EV, Stack MS (2002). Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells. J Biol Chem 277:41480-41488.
24. Nicchitta CV, Kamoun M, Williamson JR (1985). Cyclosporine augments receptor-mediated cellular Ca2+ fluxes in isolated hepatocytes. J Biol Chem 260:13613-13618.
25. Nishimura F, Naruishi H, Naruishi K, Yamada T, Sasaki J, Peters C, et al. (2002). Cathepsin-L a key molecule in the pathogenesis of drug-induced and I-cell disease mediated gingival overgrowth: a study with cathepsin-L-deficient mice. Am J Pathol 161:2047-2052.
26. Spolidorio LC, Spolidorio DM, Neves KA, Gonzaga HF, Almeida OP (2002). Morphological evaluation of combined effects of cyclosporin and nifedipine on gingival overgrowth in rats. J Periodontal Res 37:192-195.
27. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR (1983). Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 55:274-278.
28. Yue H, Uzui H, Shimizu H, Nakano A, Mitsuke Y, Ueda T, et al. (2004). Different effects of calcium channel blockers on matrix metalloproteinase-2 expression in cultured rat cardiac fibroblasts. J Cardiovasc Pharmacol 44:223-230.